The strongest evidence of association with breast cancer risk in BRCA2 mutation carriers was observed for rs6982040, located at 8q11.21 in intron 74 of the PRKDC gene (p = 2.7 × 10−3). This evidence concerns the gene PRKDC and breast carcinoma.